These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 26201664)

  • 1. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endoplasmic reticulum stress in endothelial dysfunction induced by homocysteine thiolactone.
    Wu S; Gao X; Yang S; Meng M; Yang X; Ge B
    Fundam Clin Pharmacol; 2015 Jun; 29(3):252-9. PubMed ID: 25623775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?
    Ashfield-Watt PA; Moat SJ; Doshi SN; McDowell IF
    Biomed Pharmacother; 2001 Oct; 55(8):425-33. PubMed ID: 11686575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.
    Weiss N
    Curr Drug Metab; 2005 Feb; 6(1):27-36. PubMed ID: 15720205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.
    Lentz SR; Rodionov RN; Dayal S
    Atheroscler Suppl; 2003 Dec; 4(4):61-5. PubMed ID: 14664904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory effects of homocysteine on cardiovascular diseases.
    Dai J; Wang X
    Sheng Li Xue Bao; 2007 Oct; 59(5):585-92. PubMed ID: 17940698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of homocysteine-induced atherothrombosis.
    Lentz SR
    J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.
    Takamitsu Y; Nakanishi T
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S95-9. PubMed ID: 11576931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
    Zheng H; Huang X; Zhang Q; Katz SD
    Kidney Int; 2006 Feb; 69(4):679-84. PubMed ID: 16395269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.